The Europe dermatology devices market size was valued at USD 192.7 million in 2025 and is projected to grow from USD 208.9 million in 2026 to USD 383.6 million by 2033, at a CAGR of 9.1% from 2026 to 2033. The market growth is primarily driven by the rising prevalence of skin disorders, including acne, psoriasis, eczema, rosacea, and pigmentation-related conditions, across European countries.
Increasing consumer awareness regarding aesthetic appearance and skin health, coupled with the growing demand for minimally invasive and non-invasive cosmetic procedures, is significantly supporting market expansion. In addition, advancements in laser-based dermatology technologies, including CO₂ lasers, Nd:YAG lasers, Er:YAG lasers, and radiofrequency-based systems, are improving treatment precision, safety, and patient outcomes, further accelerating adoption across hospitals, dermatology clinics, and medical spas.
The growing patient population is increasing the demand for dermatology treatments, diagnostic procedures, laser therapies, biologic drugs, and advanced skincare products. Dermatology clinics and hospitals across Europe are witnessing a rise in patient visits for both medical and cosmetic skin concerns. In particular, the increasing incidence of psoriasis and atopic dermatitis is supporting the adoption of biologic therapies and targeted treatments that provide long-term disease management. Pharmaceutical and medical device companies are therefore investing heavily in research and development to introduce more effective, minimally invasive dermatology solutions.
Furthermore, Europe’s growing elderly population is contributing significantly to market expansion, as older individuals are more susceptible to chronic and age-related skin conditions such as xerosis, pressure ulcers, skin infections, pigmentation disorders, and skin cancers. A study published in 2024 by BMC Geriatrics titled “Cutaneous Melanoma in Older Patients” reported that the incidence of melanoma is highest among elderly individuals, particularly in industrialized regions with aging populations such as Europe. The study highlighted that older adults are at greater risk of skin cancers due to cumulative ultraviolet (UV) exposure and age-related skin changes, thereby increasing the need for dermatology consultations and skin cancer treatment services. According to regional demographic trends, the proportion of the population aged 65 years and above continues to rise across many European countries, creating long-term demand for dermatological consultations and therapeutic products.
Increasing consumer awareness regarding aesthetic appearance and skin health, coupled with the growing demand for minimally invasive and non-invasive cosmetic procedures, is significantly supporting market expansion. In addition, advancements in laser-based dermatology technologies, including CO₂ lasers, Nd:YAG lasers, Er:YAG lasers, and radiofrequency-based systems, are improving treatment precision, safety, and patient outcomes, further accelerating adoption across hospitals, dermatology clinics, and medical spas.
The growing patient population is increasing the demand for dermatology treatments, diagnostic procedures, laser therapies, biologic drugs, and advanced skincare products. Dermatology clinics and hospitals across Europe are witnessing a rise in patient visits for both medical and cosmetic skin concerns. In particular, the increasing incidence of psoriasis and atopic dermatitis is supporting the adoption of biologic therapies and targeted treatments that provide long-term disease management. Pharmaceutical and medical device companies are therefore investing heavily in research and development to introduce more effective, minimally invasive dermatology solutions.
Furthermore, Europe’s growing elderly population is contributing significantly to market expansion, as older individuals are more susceptible to chronic and age-related skin conditions such as xerosis, pressure ulcers, skin infections, pigmentation disorders, and skin cancers. A study published in 2024 by BMC Geriatrics titled “Cutaneous Melanoma in Older Patients” reported that the incidence of melanoma is highest among elderly individuals, particularly in industrialized regions with aging populations such as Europe. The study highlighted that older adults are at greater risk of skin cancers due to cumulative ultraviolet (UV) exposure and age-related skin changes, thereby increasing the need for dermatology consultations and skin cancer treatment services. According to regional demographic trends, the proportion of the population aged 65 years and above continues to rise across many European countries, creating long-term demand for dermatological consultations and therapeutic products.
Europe Dermatology Devices Market Report Segmentation
This report forecasts revenue growth at the regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Europe dermatology devices market report based on product, application, end-use, and country:Product Outlook (Revenue, USD Million, 2021-2033)
Application Outlook (Revenue, USD Million, 2021-2033)
End-use Outlook (Revenue, USD Million, 2021-2033)
Country Outlook (Revenue, USD Million, 2021-2033)
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Europe Dermatology Devices Market Variables, Trends & Scope
Chapter 4. Europe Dermatology Devices Market: Product Estimates & Trend Analysis
Chapter 5. Europe Dermatology Devices Market: Application Estimates & Trend Analysis
Chapter 6. Europe Dermatology Devices Market: End Use Estimates & Trend Analysis
Chapter 7. Europe Dermatology Devices Market: Country Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Candela Medical
- Asclepion Laser Technologies
- Lumenis Be Ltd.
- Cynosure, LLC
- Lynton Lasers
- El.En. S.p.A.
- Cutera
- Termosalud
- Sisram Medical (Alma Lasers)
- Fotona
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | June 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 192.7 Million |
| Forecasted Market Value ( USD | $ 383.6 Million |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 10 |
